Mechanism of new 'sudden-death' arrhythmia detailed

November 15, 2005

Researchers have now determined the molecular mechanism underlying a cardiac arrhythmia syndrome they discovered that can lead to sudden death in young, seemingly healthy people.

The researchers -- from Duke University Medical Center, Vanderbilt University Medical Center and the Howard Hughes Medical Institute (HHMI) -- found that the disorder is caused by a mutation in an integral component of a four-protein complex that coordinates the inflow and outgo of key chemicals - especially calcium - in heart muscle cells. The passage of such ions in and out of heart muscle cells controls the beating of the heart.

The researchers found that patients with a mutation in the gene that codes for the protein known as ankyrin-B are at high risk of sudden death from cardiac arrhythmia. Ankyrin-B serves as a molecular scaffold and "cellular chaperone" for the complex.

These findings are important, the researchers said, because the new knowledge of the structure and location of the ankyrin-B complex -- as well as its importance in maintaining calcium equilibrium within heart muscle cells -- gives them targets for potential new drugs. Furthermore, the researchers said, their findings provide new insights into other disorders involving the pancreas and the eyes.

The results of the researchers were published Nov. 16, 2005, in the Public Library of Science - Biology. The research was supported by the National Institutes of Health and Johnson & Johnson, New Brunswick, N.J.

"We found that ankyrin-B forms a complex with three different proteins that allow the orderly passage of different ions in and out of the cell," said HHMI investigator and Duke cell biologist Vann Bennett, M.D., Ph.D., senior member of the research team. "The most important of these ions is calcium, since its entry into a cell causes the contraction of the cell. However, before the next heartbeat, the calcium needs to be pumped out of the cell. We found that the ankyrin-B complex acts as a safety valve that maintains the appropriate calcium balance."

However, for patients with the mutation in the gene that produces ankyrin-B, the protein complex is much less effective in maintaining this balance, making them vulnerable to the arrhythmia.

The Duke team first reported this specific mutation in ankyrin-B in 2003, based on an international study of a large French family whose members had the mutation. They later identified a specific arrhythmia in humans in 2004 that has since been termed "sick sinus syndrome with bradycardia."

While calcium is important for increasing the heart muscle cell's ability to contract, too much can cause damage to the cell, the researchers said. Once calcium enters the cell, it must quickly be pumped back out, a function that is performed by the sodium/calcium exchanger protein (NCX1), which trades incoming sodium for outgoing calcium. The sodium is then pumped out by the protein enzyme Na/K ATPase. Both of these protein "molecular pumps," NCX1 and Na/K ATPase, are located on the membranes of heart cells.

The researchers knew that ankyrin-B binds individually to NCX1 and Na/K ATPase, as well as a third receptor known as inositol 1,4,5-triphosphate receptor (InsP3R). The exact role of InsP3R is not known and is still under investigation.

"We found for the first time that ankyrin-B binds to all three of the proteins at once, forming a single multi-protein complex," said Peter Mohler, Ph.D., first author of the paper. Mohler, who is now on the faculty of Vanderbilt, performed the research at Duke while he was a HHMI post-doctoral fellow.

"Our analysis showed that the mutant ankyrin-B lost about 60 percent of its ability to bind with the other three proteins," Mohler explained. "Since the physiological effect of the mutation is loss of calcium regulation in heart cells, these results strongly suggest that binding to ankyrin-B is critical for efficiently coordinating the function of the sodium/calcium exchanger with that of Na/K ATPase to remove calcium from the cell."

Interestingly, the researchers pointed out that there are breeds of mice that have the gene for each of the three protein pumps "knocked out," and none of them exhibited heart problems. Nor do humans lacking the gene show heart problems.

"It is exciting to find that the three proteins and ankyrin-B formed one giant protein complex that clearly has a physiological function, and further that it explains why the humans with the mutation of ankyrin-B suffer from these arrhythmias," Mohler said. "Now we know why these people really die - the mutant form of ankyrin-B causes this large protein complex to fall apart."

The researchers pointed out the ankyrin-B complex is not found in skeletal muscle or smooth muscle, and its presence in heart muscle cells probably evolved as a mechanism for controlling the rapid influx, and subsequent rapid pumping out, of calcium, as would be needed during the "fight or flight" response.

Ankyrin-B is also found in nerve cells within the heart, leading researchers to believe that the gene could play important role in other aspects of heart function. It is expressed by cells in different organ systems, including certain nervous system cells, the linings of the lungs and kidneys, the retina and the insulin-producing cells of the pancreas.

"There are excitable cells within the pancreas that use calcium channels to regulate the insulin production," said Bennett, who first discovered ankyrin in 1978. "It may be possible that what we have learned about ankyrin-B's role in maintaining calcium balance in the heart may also hold true in the pancreas."
-end-


Duke University Medical Center

Related Proteins Articles from Brightsurf:

New understanding of how proteins operate
A ground-breaking discovery by Centenary Institute scientists has provided new understanding as to the nature of proteins and how they exist and operate in the human body.

Finding a handle to bag the right proteins
A method that lights up tags attached to selected proteins can help to purify the proteins from a mixed protein pool.

Designing vaccines from artificial proteins
EPFL scientists have developed a new computational approach to create artificial proteins, which showed promising results in vivo as functional vaccines.

New method to monitor Alzheimer's proteins
IBS-CINAP research team has reported a new method to identify the aggregation state of amyloid beta (Aβ) proteins in solution.

Composing new proteins with artificial intelligence
Scientists have long studied how to improve proteins or design new ones.

Hero proteins are here to save other proteins
Researchers at the University of Tokyo have discovered a new group of proteins, remarkable for their unusual shape and abilities to protect against protein clumps associated with neurodegenerative diseases in lab experiments.

Designer proteins
David Baker, Professor of Biochemistry at the University of Washington to speak at the AAAS 2020 session, 'Synthetic Biology: Digital Design of Living Systems.' Prof.

Gone fishin' -- for proteins
Casting lines into human cells to snag proteins, a team of Montreal researchers has solved a 20-year-old mystery of cell biology.

Coupled proteins
Researchers from Heidelberg University and Sendai University in Japan used new biotechnological methods to study how human cells react to and further process external signals.

Understanding the power of honey through its proteins
Honey is a culinary staple that can be found in kitchens around the world.

Read More: Proteins News and Proteins Current Events
Brightsurf.com is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to Amazon.com.